Tirzepatide Research Review: A Dual GIP and GLP-1 Receptor Agonist for Metabolic Studies
A research-focused overview of tirzepatide, a synthetic dual GIP and GLP-1 receptor co-agonist studied for its incretin mechanism, C20 fatty-diacid design for weekly pharmacokinetics, and effects on insulin secretion, glucagon, and metabolic endpoints.